Rating History for Aimmune Therapeutics (AIMT) by Wedbush

More Stocks Rated by Wedbush | Latest Ratings for AIMT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/1/2020 Liana Moussatos Downgrade Neutral
(Outperform)		 34.50
(66.00)		 12.60
(34.49)		 173.73% Details